Dr Reddys Laboratories collaborates with TR-Pharm

Image
Capital Market
Last Updated : Mar 12 2016 | 12:02 AM IST

For manufacture & commercialisation of a portfolio of biosimilar drugs in Turkey

Dr Reddys Laboratories and TR-Pharm announced a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialised as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon competition of its facility investment.

Powered by Capital Market - Live News

More From This Section

First Published: Mar 11 2016 | 11:13 AM IST

Next Story